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Abstract
Background: Developing sympathetic neurons depend on nerve growth factor (NGF) for survival and die by
apoptosis after NGF withdrawal. This process requires de novo gene expression but only a small number of genes
induced by NGF deprivation have been identified so far, either by a candidate gene approach or in mRNA
differential display experiments. This is partly because it is difficult to obtain large numbers of sympathetic neurons
for in vitro studies. Here, we describe for the first time, how advances in gene microarray technology have allowed
us to investigate the expression of all known genes in sympathetic neurons cultured in the presence and absence
of NGF.
Results: We have used Affymetrix Exon arrays to study the pattern of expression of all known genes in NGF-
deprived sympathetic neurons. We identified 415 up- and 813 down-regulated genes, including most of the genes
previously known to be regulated in this system. NGF withdrawal activates the mixed lineage kinase (MLK)-c-Jun N-
terminal kinase (JNK)-c-Jun pathway which is required for NGF deprivation-induced death. By including a mixed
lineage kinase (MLK) inhibitor, CEP-11004, in our experimental design we identified which of the genes induced
after NGF withdrawal are potential targets of the MLK-JNK-c-Jun pathway. A detailed Gene Ontology and functional
enrichment analysis also identified genetic pathways that are highly enriched and overrepresented amongst the
genes expressed after NGF withdrawal. Five genes not previously studied in sympathetic neurons - trib3, ddit3,
txnip, ndrg1 and mxi1 - were validated by real time-PCR. The proteins encoded by these genes also increased in
level after NGF withdrawal and this increase was prevented by CEP-11004, suggesting that these genes are
potential targets of the MLK-JNK-c-Jun pathway.
Conclusions: The sympathetic neuron model is one of the best studied models of neuronal apoptosis. Overall, our
microarray data gives a comprehensive overview of, and provides new information about, signalling pathways and
transcription factors that are regulated by NGF withdrawal.
Background
During normal nervous system development, neurons
depend on growth factors secreted by their target tissues
for survival [1]. These neurotrophic factors bind to cell
surface receptors on developing neurons and activate
intracellular signalling pathways that inhibit pro-
grammed cell death and promote neuronal growth. The
regulation of programmed cell death by survival factors
plays an integral part in ensuring that neuronal popula-
tions of the correct size are established [1-3]. In
addition, increasing evidence suggests that apoptosis
contributes to the neuronal loss seen after acute injuries
to the nervous system, such as stroke or trauma, or in
cell culture and animal models of neurodegenerative dis-
orders, such as Parkinson’s disease and Alzheimer’s dis-
ease [4]. Developing sympathetic neurons have proved
to be a valuable model for studying the molecular
mechanisms of apoptosis and the signalling pathways
that regulate neuronal death [5-11]. These cells require
nerve growth factor (NGF) for survival during late
embryonic and early postnatal development. When
deprived of NGF, sympathetic neurons die by apoptosis
and this death is inhibited by actinomycin D and
* Correspondence: J.Ham@ich.ucl.ac.uk
Molecular Haematology and Cancer Biology Unit, Institute of Child Health,
University College London, 30 Guilford Street, London WC1N 1EH, UK
Kristiansen et al. BMC Genomics 2011, 12:551
http://www.biomedcentral.com/1471-2164/12/551
© 2011 Kristiansen et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
cycloheximide suggesting that new gene expression is
required for cell death to occur [12]. The key prediction
of this hypothesis is that the transcription of specific
genes increases after NGF withdrawal and that the pro-
teins encoded by these induced genes trigger cell death.
To date only a limited number of induced genes that
promote apoptosis have been identified, either by study-
ing the expression of candidate genes (c-jun, bim, tp63,
puma) or in mRNA differential display experiments
(egln3). In the case of each of these genes the mRNA
and protein increases in level after NGF withdrawal and
experiments with knockout mice have demonstrated
that the gene is required for NGF withdrawal-induced
death [13-23]. However, the intracellular signalling path-
ways that are altered by NGF withdrawal - the MLK-
JNK-c-Jun pathway is activated and the PI3K-Akt and
Raf-MEK-ERK pathways are inactivated - are likely to
regulate the expression of a much larger number of
genes. Some of these genes, like bim and puma, will
directly regulate the intrinsic pathway of caspase activa-
tion. However, other genes induced after NGF withdra-
wal may be involved in other aspects of NGF
withdrawal-induced death, e.g. alterations in signalling
pathways, changes in cell shape, the decrease in the rate
of protein synthesis or neurite fragmentation. No pre-
vious study has comprehensively addressed these issues
in sympathetic neurons. Recent advances in gene micro-
array technology have allowed us to investigate the
expression of all known genes in sympathetic neurons
for the first time. The Affymetrix Rat Exon 1.0ST
microarray allows more accurate measurement of gene
expression at the whole gene level because there are
several oligonucleotide probes for each exon of a gene.
In addition, exon arrays can be used to measure the
expression of individual exons, which provides informa-
tion about alternative splicing. Microarray analysis
represents an unbiased approach to the investigation of
NGF-withdrawal induced apoptosis and will identify the
majority of the genes that are up- or down-regulated
after NGF withdrawal.
Using developing sympathetic neurons as a model sys-
tem, we have carried out a genome-wide analysis of
gene expression at 16 hours following NGF withdrawal.
Furthermore we have analysed gene expression in NGF-
deprived sympathetic neurons in the presence or
absence of the MLK inhibitor, CEP-11004 [24]. By
including CEP-11004 in our experimental design we
were able to identify which of the genes induced after
NGF withdrawal are potential targets of the MLK-JNK-
c-Jun signalling pathway, which is activated after NGF
withdrawal and required for NGF deprivation-induced
death [13,14,25-30]. To provide further insight into the
molecular mechanisms that underlie NGF withdrawal-
induced apoptosis in sympathetic neurons we also
performed functional analysis that identified highly
enriched genetic pathways. Our data provides a compre-
hensive overview of how NGF withdrawal alters signal-
ling pathways and global gene expression. This will
increase our understanding of the basic mechanisms of
neuronal apoptosis and may also identify new targets for
the development of neuroprotective drugs.
Results
Temporal analysis of NGF withdrawal induced apoptosis
in sympathetic neurons
To comprehensively study the expression of all known
genes in rat sympathetic neurons we used Affymetrix
Exon arrays to profile gene expression at 16 hours after
NGF withdrawal compared to +NGF as a control. We
selected 16 hours because this was previously defined as
the transcriptional commitment point [5] and induced
genes known to be required for NGF withdrawal-
induced death, e.g. c-jun, bim, egln3, are expressed at a
high level at this time.
To be able to relate any changes in gene expression that
we might observe to the morphological and biochemical
changes that are known to occur after NGF withdrawal we
carried out a temporal analysis of NGF withdrawal-
induced apoptosis using several well-defined markers (Fig-
ure 1). The morphological changes that occur in sympa-
thetic neurons following NGF withdrawal are apparent
after 8-12 hours of NGF deprivation (Figure 1). During
this time, the smooth appearance of the plasma membrane
is lost and the cell becomes irregular in structure. This is
accompanied by beading of the neurites. At later time-
points (16-24 h), membrane blebbing and extensive neur-
ite degeneration occur shortly before the neuron starts to
lose its structural integrity. Nuclear changes such as chro-
matin condensation and nuclear shrinkage were visualised
by staining with Hoechst dye and DNA fragmentation was
detected by TUNEL labelling. These changes occur rapidly
after NGF withdrawal but become much more apparent
from 12-16 hours (Figure 1). Other key apoptotic events
such as cytochrome c release from the mitochondria and
the activation of caspase 3 were also measured (Figure 1).
Cytochrome c is released from the mitochondria following
NGF withdrawal and eventually decreases in level. Simi-
larly, caspase 3 becomes activated and is clearly detected
in sympathetic neurons deprived of NGF from 8 hours.
We also detected an increase in c-Jun phosphorylation at
serine 63 following NGF withdrawal (Figure 1). This site is
phosphorylated by JNKs, which are activated after NGF
deprivation. Importantly, the level of c-Jun phosphoryla-
tion increases before and peaks at 16 hours. Therefore at
16 hours, the timepoint chosen for our Exon microarray
analysis, the MLK-JNK-c-Jun pathway has been activated
in many neurons, and some cells in the population are
already undergoing apoptosis.
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Gene expression profiling in sympathetic neurons after
NGF withdrawal
To identify new genes that may play a role in NGF
withdrawal-induced apoptosis, we performed a gene
microarray analysis using Affymetrix Exon arrays and
RNA isolated from sympathetic neurons that had been
cultured for 16 hours in the presence of NGF (+NGF),
absence of NGF (-NGF) or absence of NGF but with the
MLK inhibitor CEP-11004 (-NGF+CEP-11004) added to
the medium (Figure 2). MLKs are upstream activators of
the JNK pathway in sympathetic neurons and CEP-
11004 therefore blocks the increase in JNK activity and
c-Jun phosphorylation and protects against NGF with-
drawal-induced death. Three independent experiments
were performed. Quality control and data analysis
revealed good normalisation and reproducibility. An
FDR-corrected p-value of 0.05 was used as an initial cut
off to identify statistically significant differences in gene
Figure 1 Timecourse of NGF withdrawal-induced apoptosis in sympathetic neurons. Rat sympathetic neurons were cultured in the
presence of NGF for 6 days in vitro and then maintained in medium lacking NGF and containing anti-NGF antibody for the times indicated.
Timelapse microscopy shows that sympathetic neurons develop an apoptotic morphology during the first 24 hours following NGF withdrawal
with membrane blebbing (white arrows) and cell shrinkage occurring. Immunocytochemistry using a MAP2 antibody shows that between 4 and
8 hours after NGF withdrawal, neurites become fragmented and by 24 hours there are significantly fewer neurites compared to the control (0
hours). These morphological changes are accompanied by nuclear changes indicative of apoptosis visualised by Hoechst and TUNEL staining
and these are seen as early as 2-4 hours after NGF withdrawal. Importantly, c-Jun becomes phosphorylated and is localised exclusively in the
nucleus after NGF-withdrawal. Cytochrome c is released from the mitochondria and decreases in level. Finally, caspase-3 becomes activated and
is clearly detected from 8 hours following NGF deprivation. The scale bar represents 20 μm.
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expression between each of the three different treatment
groups (+NGF, -NGF, -NGF+CEP-11004). Each indivi-
dual comparison generated a list of differentially
expressed genes which were either up- or down-regu-
lated in sympathetic neurons. When comparing the
+NGF and -NGF treatment groups this analysis revealed
415 genes that were up-regulated and 813 genes that
were down-regulated (Figure 2). A more stringent statis-
tical threshold with an FDR-adjusted p-value of < 0.01
reduced this number to 164 and 379 up- and down-
regulated genes respectively. Further analysis revealed
that of the up-regulated genes with a FDR adjusted p-
value of < 0.01, 48 genes had a fold change of greater
than 2 (Additional file 1). Similarly, the expression of 86
of the genes that were down-regulated changed in level
by greater than 2-fold (Additional file 2).
We also checked our microarray data for the genes
previously shown to be regulated by NGF withdrawal in
sympathetic neurons, such as c-jun, dp5, bim, egln3 and
cyclinD1 and found that their expression had changed
as predicted (Table 1; [13-17,24,31-35]). Importantly, the
induction after NGF withdrawal of those genes pre-
viously defined as targets of the MLK-JNK-c-Jun path-
way, c-jun, bim, dp5, mkp1 [17,19,24,26,34] was reduced
by CEP-11004.
Gene Ontology analysis and unsupervised hierarchical
clustering
Gene Ontology covers three domains: cellular component,
molecular function and biological process. However, to
obtain an overview of the functional categories and the
biological relevance of the genes regulated by NGF with-
drawal, we used an alternative strategy of functional analy-
sis (rather than the standard Gene Ontology analysis).
Functional enrichment analysis of Gene Ontology terms
using DAVID identified those annotations that were sig-
nificantly overrepresented amongst the list of genes signifi-
cantly de-regulated after NGF withdrawal compared to a
reference gene list consisting of all of the annotated genes
represented on the microarray. All genes significantly up-
or down-regulated (FDR = 0.05) after NGF withdrawal
(1228 in total) were eligible for this analysis. Gene lists
that contained up- or down-regulated genes were analysed
separately. Following NGF withdrawal, major functional
categories that were especially up-regulated included
intracellular signalling cascade, ion transport and tran-
scription (Figure 3). In contrast, the down-regulated genes
appeared to be involved in cell cycle and intracellular
transport as well as nucleoside and ion binding. Interest-
ingly, twice as many genes associated with the cell death
process were down-regulated compared to up-regulated.
Figure 2 Schematic overview of gene-level analysis. Rat sympathetic neurons were cultured in vitro for 6 days and then maintained in 1)
medium containing NGF, or 2) medium without NGF supplemented with anti-NGF antibody or 3) medium without NGF containing anti-NGF
antibody and the MLK inhibitor CEP-11004 at 400 nM. Three independent experiments were performed. After 16 hours, RNA was isolated and
processed and gene expression analysed using Affymetrix rat exon microarrays. The summarisation algorithm, PLIER (Probe Logarithmic Intensity
Error) was used to compute gene-level expression values. At the gene level, we identified 1228 differentially expressed genes with a Limma FDR
(false discovery rate) adjusted p-value of < 0.05. This number of differentially expressed genes was reduced to 48 up-regulated and 86 down-
regulated genes when applying a more stringent statistical test (FDR adjusted p-value < 0.01) and an absolute fold change threshold of > 2. A -
see additional file 1 for a list of these genes. B - see additional file 2 for a list of these genes.
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Functional categories such as the ER unfolded protein
response and negative regulation of protein kinase activity
were significantly over-represented in the up-regulated
genes whilst in the down-regulated genes, categories such
as cholesterol biosynthetic process and the electron trans-
port chain were significantly enriched (Figure 3). Notably,
the proportion of up-regulated genes related to amino
acid transport and positive regulation of developmental
process was also significantly higher than expected by
chance. Finally, a significant proportion of genes asso-
ciated with the cellular components plasma membrane,
mitochondria and the ER was strikingly different between
the up- and down-regulated genes (Figure 3).
The 50 most significantly up- and down-regulated
genes were subjected to hierarchical clustering analysis
(Figure 4). Both samples and genes were clustered
according to their expression profiles using the Euclidean
distance metric to calculate dendrograms. Genes with
similar expression profiles may be regulated by common
pathways and be involved in related functions. We
observed four major patterns of gene expression (Figure
4): 1) genes induced after NGF withdrawal that require
the MLK-JNK pathway, for example dusp1 and hamp
(their induction was reduced by CEP-11004); 2) genes
induced after NGF withdrawal that may not depend on
the MLK-JNK pathway, e.g. egln3 and prg1; 3) genes that
are down-regulated after NGF withdrawal that are res-
cued by CEP-11004, e.g. hmgcr and insig1, and 4) genes
that are down-regulated after NGF withdrawal whose
decrease in expression is not affected by CEP-11004, e.g.
dusp6 and prl6a1. Genes belonging to some of the most
common networks are listed in Table 2.
Validation of gene induction after NGF withdrawal by real
time PCR
Functional enrichment analysis revealed that the annota-
tion ER-unfolded protein response was the most enriched
term after NGF withdrawal suggesting that an ER stress
response occurs in sympathetic neurons deprived of NGF.
We therefore initially selected two regulated genes from
this category for further validation. Trib3 (up-regulated
5.2-fold after NGF withdrawal) and ddit3/CHOP10 (up-
regulated 4.11-fold) were the third and ninth most up-
regulated genes respectively after NGF withdrawal (Figure
5A). The trib3 mRNA was previously shown to increase in
level after NGF withdrawal in PC12 cells [35] but nothing
is known about its role in sympathetic neurons. CHOP10
has not been studied before in sympathetic neurons. The
increase in the level of the trib3 and ddit3/chop10 mRNAs
was reduced by CEP-11004, suggesting that these genes
are potential targets of the MLK-JNK-c-Jun pathway. To
validate these exon array results, we cultured sympathetic
neurons for 6 days in the presence of NGF and then for a
further 16 hours in the presence or absence of NGF ±
CEP-11004. The levels of trib3 and ddit3 mRNA were
then measured by quantitative real time PCR (Figures 5B-
C). After NGF withdrawal, the levels of trib3 mRNA and
ddit3 mRNA increased by 3.33-fold and 3.68-fold respec-
tively but this was reduced to 0.79-fold and 1.1-fold in the
presence of CEP-11004 when normalised to gapdh (Figure
5B). A similar increase was seen in trib3 and ddit3 mRNA
levels after NGF withdrawal when normalised to hprt1
(Figure 5C). We also found that the txnip gene was signifi-
cantly up-regulated after NGF withdrawal. Txnip binds to
and inhibits thioredoxin, a major antioxidant protein in
neurons. Any perturbation of the redox system in neurons
could lead to a cellular pro-oxidant state that is a neces-
sary component of apoptotic death [36]. We found that
the txnip mRNA levels mirrored the patterns from micro-
array analysis (Figure 5). Interestingly, txnip mRNA levels
increased significantly after NGF withdrawal (up-regulated
9.03-fold) and this was reduced to 1.73-fold in the pre-
sence of CEP-11004 when measured by qPCR and nor-
malised to either gapdh or hprt1. Two other genes were
Table 1 Genes known to be regulated by NGF withdrawal
Gene symbols Gene name -NGF
v
+NGF
CEP
v
+NGF
Pathway References
Bid3/Dp5/Hrk BH3-interacting domain-containing protein 3; Dp5; harakiri 9.78 5.28 cell death 32, 34
Trib3 tribbles homologue 3 (Drosophila) 5.21 1.81 ER stress 35
Dusp1/Mkp1 dual specificity phosphatase 1;MAP kinase phosphatase 1 4.69 1.60 MAPK pathways 13, 24
Bcl2l11/Bim/Bod BCL2-like 11 (apoptosis facilitator) 4.35 1.95 cell death 16, 17
Egln3/SM-20 EGL nine homologue 3 (C. elegans) 3.41 3.53 cell death 15
Gadd45g growth arrest and DNA-damage- inducible protein 45 gamma 3.16 1.31 DNA damage inducible 33
Jun Jun oncogene; c-Jun 2.62 1.55 AP1 family 13, 14
Ccnd1 cyclin D1 1.46 1.04 cell cycle 31
Myc myelocytomatosis viral oncogene homologue (avian); c-Myc -1.76 -1.32 Myc network 31
Ngfr/p75NTR nerve growth factor receptor (TNFR superfamily, member 16); p75NTR -1.73 -1.44 neurotrophin signalling 31
The fold increase in RNA level after NGF withdrawal or after NGF withdrawal in the presence of CEP-11004 (average of 3 independent experiments) from the
microarray is shown for genes that have been previously reported to be transcriptionally regulated in this system (see references above).
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Figure 3 Functional enrichment analysis of gene ontology terms. Gene Ontology (GO)-based annotation was used to perform functional
enrichment analysis using the DAVID (v6.7) tools. Fold enrichment of NGF-withdrawal regulated genes is measured by the bar length. The
number of genes refers to the number of differentially expressed genes described by that annotation and is also expressed as a percentage of
the total genes described for that term. An FDR adjusted p-value represents the significance of the enrichment. The key represents the three
domains covered within the Gene Ontology. Only annotations with a significant FDR adjusted p-value of < 0.05 are shown.
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Figure 4 Top 50 genes up- and down-regulated in sympathetic neurons after NGF withdrawal. Heatmaps showing the expression of the
50 genes most significantly up- and down-regulated in sympathetic neurons after NGF withdrawal compared to other treatments as indicated.
Cluster analysis was performed on the genes and the treatment groups according to their expression profiles and the corresponding
dendrogram is shown to the left and to the top of the heatmap respectively. Treatment groups are colour coded as follows: blue, sympathetic
neurons cultured in the presence of NGF for 16 hours (+NGF); pink, sympathetic neurons cultured in the absence of NGF and in the presence of
an anti-NGF antibody (-NGF); yellow, sympathetic neurons cultured in the absence of NGF and in the presence of an anti-NGF antibody and the
compound CEP-11004 (+CEP). A green-red colour palette illustrates the log2 gene expression values, with green corresponding to low and red
corresponding to high expression. The numbered arrows refer to the 4 major patterns of expression as described in the results. *Genes with
unknown annotation.
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also validated by quantitative PCR: ndrg1 and mxi1. Both
of these genes are associated with the Myc gene regulation
network and are induced after NGF withdrawal by 3.18-
fold and 2.22-fold respectively. Quantitative PCR con-
firmed the increase in mRNA levels for both of these
genes (Figure 5A-C).
The protein levels of selected regulated genes increase
after NGF withdrawal
We examined the effect of NGF withdrawal on the levels
of the proteins encoded by the 5 selected genes and their
localisation. In immunoblotting experiments, we observed
a significant increase in the levels of the Trib3 and Ddit3
proteins by 16 hours after NGF withdrawal. In contrast,
when sympathetic neurons were deprived of NGF in the
presence of 400 nM CEP-11004 for 16 hours, there was
no significant increase in the levels of these proteins when
compared to neurons cultured in the presence of NGF
(Figure 6A). Levels of Trib3 and Ddit3 protein and their
subcellular localisation were also studied by immunofluor-
escence (Figure 6B). In the presence of NGF, Trib3 levels
were low and levels of Ddit3 were almost undetectable.
Table 2 Selection of genes regulated by NGF withdrawal identified in this study
GO pathway Gene
symbol
Gene name -NGF
v
+NGF
CEP
v
+NGF
AP1/ATF family CREM cAMP responsive element modulator 1.51 1.25
JunD Jun D proto-onocogene 1.74 1.60
Cell death Bmf Bcl2 modifying factor 1.91 1.31
Casp12 caspase 12 1.46 1.23
Casp3 caspase 3, apoptosis related cysteine protease 1.73 1.31
Casp4 caspase 4, apoptosis related cysteine protease 1.60 1.03
Cycs cytochrome c, somatic -1.88 -1.19
DNA damage-inducible GADD45a Growth arrest and DNA damage-inducible 45 alpha 1.45 1.41
ER stress ATF3 activating transcription factor 3 2.89 -1.69
Ddit3 DNA damage-inducible transcript 3/CHOP10 4.11 1.37
Eif2ak3 eukaryotic translation initiation factor 2 alpha kinase 3/PERK 2.28 1.54
Herpud1 homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like
domain member 1
2.17 1.17
Myd116 myeloid differentiation primary response gene 116 1.81 1.09
Fatty acid/cholesterol
metabolism
Hmgcr 3-hydroxy-3-methylglutaryl-coenzyme A reductase -2.79 -1.76
Insig1 insulin induced gene 1 -4.69 -1.51
Sc4mol sterol-C4-methyl oxidase-like -3.95 -1.36
FOXO target Txnip thioredoxin interacting protein/Vdup1 3.68 2.46
MAPK pathways Dusp6 dual specificity phosphatase 6/Mkp3 -6.68 -5.66
RhoQ Ras homologue gene family, member Q 2.51 1.16
Miscellaneous Areg amphiregulin -5.90 -5.50
Bhlhb2 basic helix-loop-helix domain containing, class B2 -2.35 -2.36
Btg1 B-cell translocation gene 1, anti-proliferative 1.78 1.44
Btg2 B-cell translocation gene 2, anti-proliferative 3.63 1.64
Chrna7 cholinergic receptor, nicotinic, alpha polypeptide 7 2.16 2.16
Cnskr3 Cnksr family member 3 (Magi1) 3.14 1.54
Pkib protein kinase (cAMP-dependent, catalytic) inhibitor beta 2.39 1.02
Tpo1 developmentally regulated protein TPO1 2.41 2.04
Myc network Id2 Inhibitor of DNA binding 2 -1.75 -1.31
Mxi1 Max interacting protein 1 2.22 1.77
Mycn v-myc myelocytomatosis viral related oncogene, neuroblastoma derived -2.89 -1.87
Ndrg1 N-myc downstream regulated gene 1 3.18 2.07
Ptma -1.93 -1.37
PI3K-Akt PIK3IP1 similar to HGFL protein 5.28 4.56
pathway PIK3r1 phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 1/p85 1.85 1.90
The fold increase in RNA level after NGF withdrawal or after NGF withdrawal in the presence of CEP-11004 (average of 3 independent experiments) is shown for
a selection of genes that have been grouped according to functional activity. The level of gene expression in the presence of NGF was set to 1. Negative fold
changes refer to down-regulation. Only genes with a FDR-adjusted p-value of < 0.01 are shown.
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Levels of these proteins started to increase after ~8 hours
peaking at 12-16 hours after NGF withdrawal. Trib3 was
localised in both the nucleus and cytoplasm, whereas
Ddit3 was localised mainly in the nucleus after NGF with-
drawal. However, in the presence of CEP-11004, the levels
of both proteins were decreased significantly to almost
basal levels and more importantly were not detected in the
nucleus. The protein levels of the other three genes:
Txnip, Ndrg1 and Mxi1 were also studied by immunoblot-
ting and immunofluorescence (Figure 6). Significant but
modest increases in the levels of the Txnip, Ndrg1 and
Mxi1 proteins were seen after NGF withdrawal and CEP-
11004 reduced this to varying degrees. The increase in
Txnip protein level after NGF withdrawal was smaller
than that seen at the transcriptional level. The effect of
CEP-11004 was also not as significant at the protein level.
The increase in the level of the Txnip protein and its loca-
lisation after NGF withdrawal were also studied by immu-
nofluorescence. The Txnip protein was clearly seen at 8
hours after NGF withdrawal in both the nucleus and cyto-
plasm and this was followed by a steady increase in pro-
tein levels over time. Both of the Myc pathway-associated
proteins, Ndrg1 and Mxi1, also increased in level after
NGF withdrawal and CEP-11004 reduced this increase
(Figure 6).
The txnip and trib3 promoters contain potential c-Jun
binding sites
We previously showed that three of the genes that are
induced after NGF withdrawal in sympathetic neurons, c-
jun, dp5 and mkp1, are direct targets of c-Jun [24,26,34].
The induction of these genes after NGF deprivation is
strongly reduced by CEP-11004 and the c-jun, dp5 and
mkp1 promoters contain functionally important ATF
sites (Figure 7A) that have been shown to bind c-Jun/
ATF2 heterodimers in chromatin immunoprecipitation
assays and EMSA experiments [24,34]. Some of the
induced genes identified in our exon array analysis might
also be direct targets of c-Jun, in particular those whose
mRNA induction after NGF withdrawal is strongly sup-
pressed by CEP-11004, for example txnip and trib3 (Fig-
ure 5B and 5C). We therefore searched for conserved
potential c-Jun binding sites in the promoter, first exon
and first intron of the rat txnip and trib3 genes (Figure
7B and 7C). The txnip promoter contains an ATF site
(TGAGGTAA), 919 bp upstream of Exon 1 in the rat
gene, that is identical in sequence to the reverse comple-
ment of the jun2 TRE site in the c-jun promoter (Figure
7A and 7B). This site is conserved in the rat, human, and
cow txnip genes and contains two base changes in the
mouse gene (Figure 7B). In the case of trib3, we identified
a conserved ATF site (TTACATCA) 14 bp upstream of
Exon 1 in the rat gene (Figure 7C). This site is identical
to the reverse complement of the ATF site in the dp5
promoter (Figure 7A) and is conserved in the rat, mouse
and cow genes and only one nucleotide differs in the
human trib3 gene (Figure 7C). The presence of these
potential c-Jun/ATF2 binding sites in the promoters of
the rat txnip and trib3 genes suggests that these genes
might be direct targets of the MLK-JNK-c-Jun pathway.
Discussion
In 1988, it was first proposed by Martin et al. [12] that
new RNA and protein synthesis is required for NGF
Figure 5 Validation of gene induction after NGF withdrawal by real time PCR. Rat sympathetic neurons were cultured in vitro for 6 days
and then maintained for 16 hours in 1) medium containing NGF, or 2) medium without NGF supplemented with anti-NGF antibody or 3)
medium without NGF containing anti-NGF antibody and the compound CEP-11004 at 400 nM. RNA was then isolated using an RNeasy kit. The
experiment was performed in triplicate and the resulting RNA samples were then processed and an Affymetrix rat exon microarray analysis was
carried out. A, The fold increase in RNA level after NGF withdrawal or after NGF withdrawal in the presence of CEP-11004 determined by exon
array analysis (average of 3 independent experiments) is shown for 5 representative genes. For each gene, the level of expression in the
presence of NGF was set as 1 and the expression levels for the other treatments were normalised relative to this. B-C, mRNA levels for the 5
genes were also measured by real time PCR using RNA prepared from three independent sets of neurons and normalised to the housekeeping
genes gapdh (B) or hprt1 (C). The data shown represents the average of three independent experiments ± SEM. Statistical comparisons were
made between +NGF and -NGF or -NGF and +CEP-11004 for each gene. *p < 0.01.
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Figure 6 The proteins encoded by the 5 selected genes increase in level after NGF withdrawal. A, Immunoblotting analysis of Trib3, Ddit3,
Txnip, Ndrg1 and Mxi1 protein levels using extracts prepared from sympathetic neurons cultured in the presence or absence of NGF ± CEP-
11004 for 16 hours. For all 5 genes, protein levels were significantly increased at 16 hours after NGF withdrawal. Representative images are
shown. c-Jun is shown as a positive control. ERK levels are shown as a loading control. The blots were scanned on a densitometer to quantitate
the levels of each protein and were normalised to the ERK loading control. The ratio of the level of each protein in the presence of NGF (+NGF)
to the level of each protein after NGF withdrawal (-NGF) or in the presence of CEP-11004 was then calculated. B, Analysis of Trib3, Ddit3, Txnip,
Ndrg1 and Mxi1 protein levels and subcellular localisation by immunocytochemistry. Sympathetic neurons were treated as indicated and fixed at
0, 2, 4, 8, 12, or 16 hours after NGF withdrawal ± CEP-11004. The cells were then stained with the appropriate primary antibody followed by a
FITC-conjugated secondary antibody, and Hoechst dye to label the nuclear DNA. Images were collected using the same exposure time for each
timepoint and the coverslips in each gene group were analysed in parallel. The scale bar represents 20 μm.
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withdrawal-induced apoptosis in sympathetic neurons.
However, since then only a small number of genes have
been shown to be regulated in this system and these
were identified either by candidate gene approaches or
the differential display technique. This is partly because
it is difficult to obtain large numbers of sympathetic
neurons for in vitro studies. However, advances in tech-
nology have now allowed us to identify the majority of
the genes regulated by NGF withdrawal in sympathetic
neurons. Using Affymetrix exon arrays and RNA iso-
lated from rat sympathetic neurons, we investigated the
global pattern of gene expression at 16 hours after NGF
withdrawal. This time-point represents the transcrip-
tional commitment point for sympathetic neurons
undergoing NGF withdrawal-induced apoptosis and
induced genes known to be required for NGF withdra-
wal-induced death, e.g. c-jun, bim, and egln3, are
expressed at a high level at this time. We were able to
detect almost all of the genes known to be regulated
after NGF withdrawal (Table 1) indicating the reliability
of the microarray data. However, one exception was the
previously described up-regulated gene puma [19] which
is required for NGF withdrawal-induced death [21]. On
further investigation, we found that no probe sets
matching the puma gene were represented on the rat
Affymetrix exon 1.0ST microarray. Nevertheless, micro-
array technology remains a reliable tool and represents
the best method for obtaining a complete overview of
patterns of gene expression in this system. In addition,
microarray studies can identify candidate genes for func-
tional studies. For example, in the microarray experi-
ments described in this paper we identified mkp1 as a
gene induced after NGF withdrawal that could be a tar-
get of the MLK-JNK-c-Jun pathway. We subsequently
showed that mkp1 is a direct transcriptional target of
the MLK-JNK-c-Jun pathway in sympathetic neurons
and an important regulator of JNK activity and the rate
of NGF withdrawal-induced death [24]. Microarrays
have previously been used to study gene expression in
potassium-deprived cerebellar granule neurons under-
going apoptosis [37]. The most highly up-regulated gene
in this study, trim17, was subsequently shown to encode
a novel E3-ubiquitin ligase that can initiate neuronal
apoptosis in several in vitro models of transcription-
dependent apoptosis, including cerebellar granule neu-
rons and NGF-deprived sympathetic neurons [38].
Approximately 95% of the genes identified in our
microarray study have never been shown before to be
transcriptionally regulated during NGF withdrawal-
induced apoptosis. We have been able to identify poten-
tial targets of the MLK-JNK-c-Jun pathway by including
CEP-11004 in our experimental design. We selected 16
hours as the optimal time-point for our microarray
Figure 7 The txnip and trib3 promoters contain potential c-Jun
binding sites. A, DNA sequences of functionally important ATF sites
known to bind c-Jun and ATF2 in the c-jun, dp5 and mkp1
promoters. The c-jun promoter contains two ATF sites, the jun2 and
jun1 TREs, the dp5 promoter contains one site, and the mkp1
promoter contains two sites. Each of these sites has been shown to
bind c-Jun and ATF2 in ChIP assays and to be important for
promoter induction after NGF withdrawal [24,26,34]. The orientation
of the sequences is 5’ to 3’. B, A conserved ATF site was identified
in the txnip promoter using CONSITE software (http://asp.ii.uib.
no:8090/cgi-bin/CONSITE/consite) to analyse orthologous pairs of
genomic sequences. This sequence (5’-TGAGGTAA-3’) is identical to
the reverse complement of the jun2 TRE (5’-TTACCTCA-3’) in the c-
jun promoter. Numbers refer to position in relation to Exon 1 of the
rat txnip gene, as defined in the NCBI entry for rat txnip (http://
www.ncbi.nlm.nih.gov/gene/117514). * indicates nucleotides
conserved in all four species. Two non-conserved nucleotides in the
mouse ATF site are shown in red. C, A conserved ATF site was
identified in the trib3 promoter using CONSITE software to analyse
orthologous pairs of genomic sequences. This sequence (5’-
TTACATCA-3’) is identical to the reverse complement of the ATF site
in the dp5 promoter. Numbers refer to position in relation to Exon 1
of the rat trib3 gene, as defined in the NCBI entry for rat trib3
(http://www.ncbi.nlm.nih.gov/gene/246273). * indicates nucleotides
conserved in all four species. One non-conserved nucleotide in the
human ATF site is shown in red.
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study and therefore identifying those genes and path-
ways that define the dying neurons at this time point
could add to our understanding of the molecular
mechanisms involved in the neuronal death programme.
In our data set, we identified 164 genes that were sig-
nificantly up-regulated (FDR, p < 0.01) after NGF with-
drawal and the expression of 48 of these genes
increased by more than 2-fold. Conversely, 379 genes
were down-regulated when the significance threshold
was set at p = 0.01 and the expression of 86 of these
genes decreased by 2-fold or more. We performed Gene
Ontology (GO) analysis and functional enrichment ana-
lysis to identify specific annotations that were enriched
following NGF withdrawal. Whilst this type of analysis
depends upon a controlled vocabulary and therefore has
its limitations, it also represents a powerful method for
extracting potentially useful biological information from
our gene expression data.
In an analysis of transcription-dependent neuronal
apoptosis proceeding via the mitochondrial pathway,
functional categories such as intracellular signaling cas-
cades, transcription and mitochondrial changes might be
expected to be enriched. Whilst these categories are
indeed enriched after NGF withdrawal, other categories
that contain genes which could suggest additional
hypotheses about the mechanisms of neuronal death
were also highlighted. The significance of the induction
of ER stress-associated genes, for example, may offer
new insights into the cell death process, especially since
a similar response was observed in cerebellar granule
neurons undergoing apoptosis [37] and experiments in
other systems suggest a role for interactions between
the mitochondria and the ER. On the other hand, the
down-regulation of genes associated with cholesterol
and fatty acid biosynthesis may be associated with an
inhibition of cell growth since cholesterol and fatty acids
are required for the synthesis of membranes.
Cluster analysis allowed us to group the genes accord-
ing to their pattern of expression, especially in the pre-
sence of the MLK inhibitor, CEP-11004. The expression
of many of the genes induced after NGF withdrawal is
reduced by CEP-11004, suggesting that they may be tar-
gets of the MLK-JNK-c-Jun pathway. This group
includes c-jun, dp5 and mkp1 whose promoters contain
ATF sites that bind c-Jun and which are important for
their induction after NGF withdrawal (Figure 7A)
[24,26,34]. The induction of a few genes, such as egln3,
is not affected by CEP-11004, suggesting that the tran-
scription of these genes may be regulated by other tran-
scription factors that are activated after NGF
withdrawal, but not regulated by the JNK pathway, for
example, FOXO3a or Myb. Interestingly, CEP-11004
reverses the decrease in the level of expression of some
of the genes that are down-regulated after NGF
withdrawal. Many of these genes encode proteins
involved in fatty acid metabolism and cholesterol meta-
bolism, e.g. insig1, sqle, hmgcr, and hmgcs1, and their
transcription is activated by sterol regulatory element-
binding proteins (SREBPs). In sympathetic neurons, the
MLK-JNK-c-Jun pathway may negatively regulate the
activity of a key transcription factor or signaling protein
that is important for the transcription of this set of
genes.
The expression of only a small number of cell death
genes changes after NGF withdrawal. Bim, dp5, and
puma mRNA levels have been previously shown to
increase after NGF deprivation and in this study we
have confirmed this for bim and dp5. We also found
that the bmf, caspase-12, caspase-3, and caspase-4
mRNAs increase in level whereas the expression of cyto-
chrome c and prothymosin alpha (ptma; an inhibitor of
the apoptosome; [39]) decreases after NGF withdrawal
(Table 2). Thus in sympathetic neurons, as previously
described for cerebellar granule neurons [37], the
expression of the components of the intrinsic pathway
(bax, cytochrome c, apaf-1, caspase-9), which are all
essential for cell death, is not greatly altered by NGF
withdrawal. However, what does change significantly is
the level of expression of four genes that encode BH3-
only proteins that activate the intrinsic pathway: dp5,
bim, bmf (Tables 1 and 2) and puma [19].
NGF-deprived sympathetic neurons undergo several
biochemical and morphological changes before commit-
ting to the neuronal death programme and some of
these are likely to play an important role in triggering
apoptosis. Interestingly, levels of mitochondrial-pro-
duced reactive oxygen species (ROS) are known to
increase early after NGF withdrawal [40] and this causes
a cellular pro-oxidant state which appears to be required
for the release of cytochrome c [40]. The regulation of
cellular redox balance is critically determined by the
activity of several antioxidant systems [41,42] one of
which is the thioredoxin system [42]. Thioredoxin itself
is regulated by an endogenous inhibitor, Txnip [43,44]
and a reduction in thioredoxin activity due to an
increase in Txnip levels might lead to increased oxida-
tion of thiol groups in cellular proteins and ultimately
an increase in apoptosis. We found a 9-fold increase in
the level of the txnip mRNA after NGF withdrawal and
this was reduced to 1.73-fold in the presence of CEP-
11004 (Figure 5) which was confirmed in NGF-depen-
dent differentiated PC6-3 cells (data not shown). Impor-
tantly, the level of Txnip protein also increased
significantly after NGF withdrawal and this increase was
prevented by CEP-11004 (Figure 6). These data suggest
that txnip is a potential target of the MLK-JNK-c-Jun
pathway and may play an important role in triggering
the apoptotic programme after NGF withdrawal.
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The endoplasmic reticulum (ER) plays a significant
role in how cellular proteins are processed, folded, mod-
ified and transported. In neurodegenerative diseases,
these cellular processes may go wrong leading to various
levels of ER stress that may contribute to neuronal
death [45]. When sympathetic neurons are treated with
the ER-stressor, tunicamycin, c-Jun becomes phosphory-
lated but this can be prevented using CEP-11004 [46].
Bcl-2 and Bcl-xL have been found to associate with both
the mitochondrial outer membrane and the ER mem-
brane and it has been reported that crosstalk can occur
between the ER and the mitochondria in cells under-
going apoptosis [47,48]. We found that two of the most
up-regulated genes after NGF withdrawal, trib3 and
ddit3, are associated with the ER-unfolded protein
response and CEP-11004 prevented their increase in
expression suggesting that they are potential MLK-JNK-
c-Jun targets (Figure 5). Furthermore, functional analysis
revealed that the ER unfolded protein response annota-
tion was the most overrepresented gene category after
NGF withdrawal suggesting that an ER stress response
occurs in sympathetic neurons under these conditions.
The exact role of these genes in ER stress-induced
apoptosis remains unclear, however, it has been shown
that CHOP10, a known AP-1 target gene, is induced by
both ER stress and oxidative stress [49]. A propapopto-
tic role for CHOP10 has been reported since its overex-
pression can lead to apoptosis [50], whilst MEFs derived
from CHOP10-/- mice are resistant to ER stress-induced
cell death [51]. However, the mechanism by which
CHOP induces apoptosis still remains unclear. It has
been shown that CHOP-induced cell death is associated
with the translocation of Bax from the cytosol to the
mitochondria and that CHOP-induced cell death can be
prevented by the overexpression of Bcl-2 or the knock-
down of Bax [52]. The link between CHOP and Bax
translocation could involve a novel ER-stress inducible
gene, trib3. It has been shown that trib3 is induced via
the ATF4-CHOP pathway through the identification of
a CHOP-binding site in the proximal portion of the pro-
moter [53]. Also, ER stress can activate bim through
CHOP-C/EBPa dependent transcriptional activation
[54] and in other studies CHOP has been found to bind
to the promoter of the proapoptotic Bcl-2 family mem-
ber puma [55]. The relationship between ER stress,
CHOP, Trib3 and BH3-only proteins may suggest an
important role in the apoptotic pathway after NGF with-
drawal. Furthermore, we also identified a conserved ATF
site (TTACATCA) 14 bp upstream of Exon 1 in the rat
trib3 gene (Figure 7C) which is identical to the reverse
complement of the ATF site in the dp5 promoter. This
potential c-Jun/ATF2 binding site in the promoter of
the rat trib3 gene suggests that this gene might also be
a direct target of the MLK-JNK-c-Jun pathway. We also
found evidence of an increase in Trib3 and Ddit3/
CHOP10 protein levels after NGF withdrawal and this
increase was prevented by CEP-11004 (Figure 6).
NGF withdrawal leads to a decrease in PI3K and Akt
activity resulting in FOXO activation. FOXO3a translo-
cates into the nucleus [56,57] and has been shown to
trigger apoptosis by activating the transcription of genes
necessary for cell death, such as bim. The mxi1 gene is
also a target of FOXO3a, which binds to sites in the
first intron downstream of the Mxi1-SRa promoter [58].
Mxi1 dimerises with Max and binds to E-boxes and
represses c-Myc and MycN target genes by recruiting
co-repressors to their promoters [59]. Interestingly, the
mxi1 mRNA increases in level after NGF withdrawal
(Figure 5) whereas c-myc and mycn mRNA levels
decrease (Tables 1 and 2). Overexpression of MycN in
sympathetic neurons has been shown to partially protect
against NGF withdrawal-induced death [60], so by
antagonising MycN, Mxi1 might have a proapoptotic
role in this system. Furthermore, the expression of
genes that are activated by c-Myc and MycN decreases
after NGF deprivation, for example id2 and ptma (Table
2). Ptma can act as a repressor of the apoptosome [39]
so it will be interesting to determine whether Ptma pro-
tein levels also decrease after NGF withdrawal. Conver-
sely, the expression of genes repressed by c-Myc and
MycN increases after NGF deprivation, for example,
ndrg1 (Figures 5 and 6 and Table 2).
Conclusions
The sympathetic neuron model is one of the best stu-
died models of neuronal apoptosis. For the first time,
we now have a global overview of the changes occurring
at the transcriptional level in NGF-deprived sympathetic
neurons. In the future, it will be interesting to determine
how the regulated genes identified in this study contri-
bute to the NGF withdrawal-induced death pathway.
This may lead to the identification of new targets for
the development of neuroprotective drugs that inhibit
neuronal death following acute injuries to the nervous
system or in neurodegenerative diseases.
Methods
Cell culture
Animal experiments were performed according to the
Animals (Scientific Procedures) Act 1986 under a
license reviewed and approved by the Biological Services
Unit at University College London. Sympathetic neurons
were isolated from the superior cervical ganglia (SCG)
of 1-day-old Sprague Dawley rats (Biological Services
Unit, University College London, UK) and cultured in
Dulbecco’s modified Eagle medium (DMEM; Life Tech-
nologies, USA) supplemented with 10% fetal calf serum
(FCS), 2 mM glutamine (Invitrogen Ltd, UK) and
Kristiansen et al. BMC Genomics 2011, 12:551
http://www.biomedcentral.com/1471-2164/12/551
Page 13 of 17
penicillin-streptomycin as described previously (SCG
medium; [61]). To limit the proliferation of non-neuro-
nal cells, the antimitotic agents fluorodeoxyuridine and
uridine (Sigma Aldrich) were added to the SCG medium
at a final concentration of 20 μM. For some experi-
ments, 2.5S NGF (Cedarlane, Canada) was also added to
SCG medium at a final concentration of 50 ng/ml. Neu-
rons were plated on 13 mm diameter glass coverslips
coated with poly-L-lysine and laminin placed in 3.5 cm
diameter dishes containing 2 ml of SCG medium and
NGF for 5-7 days. In NGF withdrawal experiments, neu-
rons were washed twice in SCG medium lacking NGF
and then refed with SCG medium supplemented with a
neutralising anti-NGF antibody at 100 ng/ml (Chemicon
Europe Ltd, UK). The MLK inhibitor, CEP-11004
(Cephalon, Inc., USA) was dissolved in DMSO and used
at a final concentration of 400 nM.
RNA extraction
Total RNA was isolated from sympathetic neurons cul-
tured for 7 days using an RNeasy mini kit (Qiagen). An
on-column DNase digestion was performed to eliminate
genomic DNA contamination using DNase I according
to the manufacturer’s instructions (Qiagen). RNA con-
centrations were determined using a NanoDrop spectro-
photometer (ND-1000). RNA was further analysed for
integrity and quality on an Agilent Bioanalyser.
Array hybridisation
Up to 2 μg of total RNA was processed and labelled
using the Affymetrix GeneChip Whole Transcript Sense
Target Labelling Assay as outlined in the manufacturer’s
instructions. Hybridisation to Affymetrix Rat Exon 1.0
ST arrays was performed for 16 hours at 45°C with con-
stant rotation. Exon array data are available from the
ArrayExpress database (http://www.ebi.ac.uk/arrayex-
press) under accession number E-MTAB-696.
Analysis of array data
Signal estimates and normalisation for gene-level ana-
lysis were generated using the Probe Logarithmic
Intensity Error Estimation (PLIER) algorithm imple-
mented in the Expression Console software (Affyme-
trix). Only core, non cross-hybridising probe sets that
map to well-annotated exons were included. To reduce
noise, probe sets and transcript clusters which fell into
the lowest quartile of the expression signal distribution
across all samples were excluded from the dataset. Sig-
nal values were analysed using Bioconductor (R). Gene
expression values were compared between the three
sample groups (+NGF, -NGF and -NGF+CEP-11004)
using the moderated t-statistic of the Bioconductor
package, Limma [62]. To correct for multiple testing at
the gene level, the Benjamini-Hochberg (FDR) test was
applied to identify statistically significant differentially
expressed genes (FDR adjusted p-values < 0.05). Lists
of significantly up- and down-regulated genes obtained
from statistical comparisons were subjected to func-
tional enrichment analysis using DAVID annotation
tools [63].
Real-time quantitative PCR
Up to 1 μg of total RNA was reverse transcribed into
cDNA using SuperScript II reverse transcriptase (Invi-
trogen) and oligo(dT) as described previously [64]. Ten
nanograms of cDNA template was used for real time
quantitative PCR using the ABI-Prism 7900HT fast
Sequence Detection System (Applied Biosystems, War-
rington, UK). Txnip, ddit3, trib3, ndrg1 and mxi1
mRNA levels were normalised to the level of the control
genes, gapdh or hprt1. Pre-optimised Taqman® gapdh
(Rn99999916_s1), hprt1 (Mn00446968_m1), txnip
(Rn01533885_g1), trib3 (Rn00595314_m1), ddit3
(Rn00492098_g1), ndrg1 (Rn01506130_m1), and mxi1
(Rn00565846_m1) primer/probe sets were supplied by
Applied Biosystems. QPCR reactions were set up with 1
× primer/probe set and 1 × Taqman® PCR Master Mix
(Applied Biosystems). PCR conditions were 95°C for 20
seconds, followed by 40 cycles of 95°C for 1 second and
60°C for 20 seconds. QPCR data was analysed using the
2-ΔΔCT relative quantitation method [65].
Immunoblotting
Immunoblotting was performed as described previously
[24]. Briefly, sympathetic neurons were harvested in 1
ml of ice-cold PBS, spun down and lysed in sample buf-
fer (2% SDS, 2 mM b-mercaptoethanol, 60 mM Tris,
pH 6.8, 0.01% bromophenol blue) for 10 minutes at
100°C. Proteins were separated on 12% SDS polyacryla-
mide gels and transferred to Immobilon-P (Millipore).
After blocking for 45 min with 5% non-fat milk in TBS
supplemented with 0.5% Tween-20, the membrane was
incubated with different primary antibodies overnight at
4°C.
The following primary antibodies were used: rabbit
polyclonal Trib3 antibody (M-165; Santa Cruz, USA),
rabbit polyclonal Ndrg1 antibody (H-60; Santa Cruz),
mouse monoclonal Txnip antibody (MBL International,
Woburn, USA), mouse monoclonal CHOP10/Ddit3 anti-
body (B3; Santa Cruz), rabbit polyclonal Mxi1 antibody
(G16; Santa Cruz), mouse monoclonal c-Jun antibody
(BD Transduction Laboratories). Equivalent protein
loading was confirmed by using a rabbit polyclonal ERK
1/2 antibody (Cell Signalling Technology).
Immunofluorescence
Sympathetic neurons cultured on poly-L-lysine/laminin-
coated glass coverslips were fixed using 4%
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paraformaldehyde at room temperature for 20 min,
washed three times with PBS, and then permeabilised
with 0.5% Triton X-100 in PBS at room temperature for
5 min. Neurons were then incubated in 50% normal
goat serum in 1% BSA in PBS for 30 min at room tem-
perature. After washing, neurons were incubated with
primary antibody for 1 hour at room temperature, fol-
lowed by a 45 min incubation with secondary antibody
at room temperature. The following antibodies were
used: mouse monoclonal phospho-c-Jun (ser63) anti-
body (Santa Cruz), rabbit polyclonal activated caspase-3
antibody (Abcam), mouse monoclonal cytochrome c
antibody (BD Biosciences, Oxford, UK), rabbit polyclo-
nal MAP2 antibody (Millipore). Fluoroscein- or rhoda-
mine-conjugated goat anti-rabbit or anti-mouse
secondary antibodies (Stratech, UK) were typically used
at a dilution of 1:250. Neurons were rinsed in PBS and
nuclei stained with DAPI dye in Antifade (DAKO) or
Hoechst dye and mounted on glass slides. TUNEL stain-
ing was performed using an in situ cell death detection
kit (Roche) according to the manufacturer’s protocol.
Microscopy and image collection
Slides were viewed on a Zeiss Axioplan 2 microscope
using a Plan-Apochromat 63x/1.40 oil objective.
Images were captured at room temperature (20°C)
using a Quantix digital camera (Photometrics, USA)
and SmartCapture VP software. For the different
treatments for each gene, the optimal exposure time
was determined using the +NGF (0 hour) coverslip
and was kept constant for all subsequent images for
the remaining timepoints. For immunofluorescence
time course experiments, all coverslips in each series
for a particular gene were analysed in parallel and
then saved as TIFF files and viewed using Adobe
Photoshop CS4. Brightfield images were collected
using a Zeiss Axiovert 200 M microscope with a Plan-
Apochromat 63x/1.40 oil objective. The microscope
stage was maintained at 37°C with 5% CO2. Images
were captured using a Zeiss axiocam and Axiovision
4.0 software.
Statistical analysis
The statistical significance of differences between means
was analysed by performing an unpaired Student’s T-
test (for two-tailed distributions). To compare normal-
ised data to a control sample, that has no error asso-
ciated to it (for example, where +NGF is set to 1), the
log10 values of the data were taken and a one sample
T-test was used (for two-tailed distributions) as pre-
viously described [57]. All data are presented as the
mean ± S.E. of multiple experiments and significance is
expressed as follows *P< 0.01.
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